Placebo News and Research

RSS

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health. The study was conducted at Northwestern Medicine and the University of Illinois at Chicago.

28 Nov 2017

Treatment of abnormal vaginal microbiota prior to embryo transfer may improve reproductive outcomes

High levels of two specific vaginal bacteria (Atopobium vaginae and Gardnerella vaginalis) serve as diagnostic markers of an abnormal vaginal microbiota that might cause impaired implantation and subsequent poor reproductive outcome.

28 Nov 2017

New study tests pain treatment in humans

Nerve growth factor signals through receptors of the tropomyosin-related kinase (Trk) family, and research in animals has shown that inhibitors of Trks A, B, and C can reduce pain.

27 Nov 2017

Decompression surgery may offer no additional benefit for people with shoulder impingement

Decompression surgery does not reduce shoulder pain any more than placebo surgery for people with shoulder impingement – when the tendon rubs and catches in the joint, according to the first placebo-controlled trial in shoulder surgery published in The Lancet.

22 Nov 2017

UZH leads Europe's largest research on aging

What began in 2012 is now entering its final stages: Europe's largest study on aging. The international research network behind the DO-HEALTH study is led by Heike Bischoff-Ferrari, Professor of Geriatric Medicine and Aging Research at the University of Zurich, and Head of the Department of Geriatrics at the UniversityHospital Zurich and the Waid City Hospital in Zurich, Switzerland.

20 Nov 2017

Trial shows apple allergen as effective treatment option for birch pollen-related apple allergy

The food allergy, which is related to birch pollen, is a very common attendant phenomenon associated with birch pollen allergy - indeed around 70% of those with a birch pollen allergy are also allergic to apples. That amounts to around 280,000 people in Austria.

20 Nov 2017

New study further validates use of vaginal progesterone to decrease risk of preterm birth

A new study published today - World Prematurity Day - in the American Journal of Obstetrics & Gynecology provides additional support for treatment with vaginal progesterone to reduce the risk of preterm birth, neonatal complications and infant death in pregnant women with a short cervix.

17 Nov 2017

Vaginal progesterone decreases the risk of premature birth in women with short cervix

A meta-analysis of placebo-controlled data published today indicates that vaginal progesterone reduces preterm birth and neonatal complications in women with a mid-trimester short cervix.

17 Nov 2017

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

The U.S. Food and Drug Administration today approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy).

17 Nov 2017

Skin patch offers hope for people with peanut allergy

People who suffer from life-threatening peanut allergies may soon be able to cure their condition by wearing a skin patch, according to the findings of a phase 2 trial.

16 Nov 2017

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.

15 Nov 2017

Stem cell therapy fails to improve walking ability in people with PAD

A stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements, according to the results of a new Northwestern Medicine clinical trial.

15 Nov 2017

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

14 Nov 2017

PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease

Patients with peripheral artery disease (PAD) are at high risk of heart attack, stroke and cardiovascular death. In addition, PAD patients can suffer major adverse limb events, such as acute limb ischemia - the equivalent of a heart attack in the leg - that can lead to limb loss.

14 Nov 2017

New drug offers hope for osteoarthritis patients suffering from debilitating hand pain

Osteoarthritis is the most prevalent arthritis worldwide and is characterized by chronic pain and impaired physical function.

13 Nov 2017

Special electric dressing can combat antibiotic resistance, biofilm infection

Researchers at The Ohio State University Wexner Medical Center have shown - for the first time - that special bandages using weak electric fields to disrupt bacterial biofilm infection can prevent infections, combat antibiotic resistance and enable healing in infected burn wounds.

6 Nov 2017

ORBITA trial on heart stents for stable angina indicates placebo effect potential

A new study conducted by researchers at the Imperial College London suggests that the placebo effect experienced by patients who receive coronary artery stents might be larger than expected, even though stents themselves are life-saving.

6 Nov 2017

Trial indicates blood-plasma infusions for Alzheimer’s patients are safe and may be effective

Researchers from Stanford University School of Medicine have found that giving blood plasma infusions taken from young donors to people with mild-to-moderate Alzheimer’s disease is not only safe and feasible, but may improve recipients’ functional ability and capacity to perform daily tasks.

6 Nov 2017

Study points to novel, effective treatment for CKD patients with metabolic acidosis

Patients with chronic kidney disease (CKD) often develop a condition called metabolic acidosis, which is characterized by an imbalance in acid production relative to excretion.

6 Nov 2017

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.

3 Nov 2017

Placebo News and Research

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

Treatment of abnormal vaginal microbiota prior to embryo transfer may improve reproductive outcomes

New study tests pain treatment in humans

Decompression surgery may offer no additional benefit for people with shoulder impingement

UZH leads Europe's largest research on aging

Trial shows apple allergen as effective treatment option for birch pollen-related apple allergy

New study further validates use of vaginal progesterone to decrease risk of preterm birth

Vaginal progesterone decreases the risk of premature birth in women with short cervix

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

Skin patch offers hope for people with peanut allergy

FDA approves drug to treat pediatric, adult patients with rare Sly syndrome

Stem cell therapy fails to improve walking ability in people with PAD

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease

New drug offers hope for osteoarthritis patients suffering from debilitating hand pain

Special electric dressing can combat antibiotic resistance, biofilm infection

ORBITA trial on heart stents for stable angina indicates placebo effect potential

Trial indicates blood-plasma infusions for Alzheimer’s patients are safe and may be effective

Study points to novel, effective treatment for CKD patients with metabolic acidosis

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News